Volume 22, Issue 3

Original Research

1. Article

   The relationship of selected biomarkers of gut microbiota dysbiosis with adiposity and metabolic risk factors in nascent metabolic syndrome patients

   Maysa Suyagh, Violet Kasabri, Nailya Bulatova, Sumaya AbuLoha, Jameel Al-Bzour, Reem AlQuoqa

   pp. 1–18 · DOI: 10.18549/PharmPract.2024.3.3017 · Published 14 August 2024

   Background: This study aimed to compare and correlate between non-diabetic MetS, newly diagnosed drug naive pre-diabetic MetS patients vs. lean, apparently healthy and normoglycemic controls the plasma levels of cardiome…

2. Article

   Evaluation of hyperkalemia associated with intravenous co-trimoxazole in hospitalized patients in Oman

   Dalia Abdalaziz, Ibrahim Al-Zakwani, Aly Abdelrahman, Ibrahim Hamdy, Yousuf AlSuleimani

   pp. 1–9 · DOI: 10.18549/PharmPract.2024.3.3004 · Published 8 August 2024

   Co-trimoxazole is a combination of two antimicrobial drugs, (trimethoprim and sulfamethoxazole), that are used to treat a wide variety of infections such as urinary tract infection, pneumocystis pneumonia and traveler’s …

3. Article

   An evaluation of pharmacy students' knowledge, attitudes and risk perceptions about HIV/AIDS

   Fahad Alzahrani, Abdulrahman Almohammadi, Moayad Alhejaili, Saad Almukhlifi, Emad Aloufi, Ahmad Alhudhayban, Abdulrahim Khan, Faris S. Alnezary

   pp. 1–8 · DOI: 10.18549/PharmPract.2024.3.2998 · Published 18 July 2024

   Background: Despite considerable progress in diagnosis, treatment, and prevention, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) remain major public health issues in Saudi Arabia. Phar…

4. Article

   Knowledge, Attitudes, and Behaviors Regarding Antibiotic Use for Children Under 5 Years Old Among Mothers in Rural Northern Vietnam

   Ba Kien Tran, Thi Nhan Nguyen, Quang Loc Duyen Vo, Thi Hai Yen Nguyen, Van De Tran, Duyen Thi My Huynh

   pp. 1–9 · DOI: 10.18549/PharmPract.2024.1.2995 · Published 10 July 2024

   Background: The use of antibiotics in children is influenced by the knowledge, attitudes, and behaviors of caregivers, especially mothers. Objective: This study aimed to assess the knowledge, attitudes, and practices reg…

5. Article

   Ciclesonide inhaler for post-acute COVID-19 syndrome: promising clinical evidence

   Sabin Thomas, Sathvik Belagodu Sridhar, Javedh Shareef, Sujith Haridas, Mullaicharam Bhupathyraaj

   pp. 1–6 · DOI: 10.18549/PharmPract.2024.3.2990 · Published Jul-Sep 2024

   Background: Long-term COVID-19 symptoms are a serious health concern and impact medical resource utilization. Lung involvement in this pandemic due to the transmission trajectory elicits appropriate therapeutic managemen…

6. Article

   Assessment of proton pump inhibitors utilization in intensive care units patients of a tertiary care hospital in the United Arab Emirates

   Ahmad El Ouweini, Keerthana Slevaraju, Victor Oladapo Olaitan, Terri Levien, Diana Malaeb

   pp. 1–6 · DOI: 10.18549/PharmPract.2024.3.2978 · Published 4 July 2024

   Background: PPI prescriptions have consistently increased in hospitals and ambulatory care facilities. Because PPIs are widely used, readily available, highly effective, and heavily marketed, they are susceptible to over…

7. Article

   The price of health: unveiling the cost of diabetes treatment in Kingdom of Saudi Arabia (KSA); A systematic literature review protocol

   Mohammed Kanan, Bader Alharbi, Ahmed Alshammari, Rahaf Alshammari, Abrar Alsayed, Budur Alshammari, Norah Aldhfiri, Mohammed Bamuflih, Moussa Alkhateeb, Reem Alqahtani, Nawal Asiri, Waad Alnami, Reema Alghaseb, Abdullah Almatrafi, Raghad Jan

   pp. 1–7 · DOI: 10.18549/PharmPract.2024.3.2972 · Published 10 July 2024

   Background: Non-communicable diseases (NCDs) place significant financial burdens on individuals, communities, and countries. However, very little information is available regarding the extent of diabetes expenses in the …

8. Article

   A longitudinal study of UK pharmacists' resilience, burnout and wellbeing throughout the COVID-19 pandemic

   Catherine Langran, Amina El-Beik, Louise Hughes, Efi Mantzourani, Kat Hall, Sarah Willis

   pp. 1–13 · DOI: 10.18549/PharmPract.2024.3.2929 · Published 18 August 2024

   Background: The COVID-19 pandemic significantly increased pressure on healthcare services globally. However, the impact of this prolonged and ever-changing pressure on pharmacist wellbeing, burnout and resilience is unex…

9. Article

   Development of an Automated System for Managing the Movement of Pharmaceutical Products in Pharmacies

   Clara D. Shertaeva, Gulnara I. Utegenova, Olga V. Blinova, Rabiga M. Anarbaeva, Aigul Zh. Serikbaeva, Sholpan L. Akhelova, Ayat U. Agabek, Aidana D. Orynbayeva, Sayora K. Jabarkulova, Bayan I. Tursubekova

   pp. 2915 · DOI: 10.18549/PharmPract.2024.3.2915 · Published 4 July 2024

   Background: In the contemporary context, a factor in the successful development of pharmaceutical organizations is the active use of information and communication tools both for work with customers and suppliers, and in …

10. Article

    Evaluation of the prevalence of anxiety and depression and the impact of asthma control level on these parameters among asthmatic patients

    Rawa Ibrahim AL-awaisheh, Iman A. Basheti, E Abu-Gharbieh

    pp. 2954 · DOI: 10.18549/PharmPract.2024.3.2954 · Published 4 July 2024

    Objectives: This study is designed to assess the prevalence of anxiety and depression among asthmatic patients living in Amman, Jordan. Additionally, it evaluates the effect of asthma control levels using the correct inh…

11. Article

    Assessment of Look-Alike, Sound-Alike Similarities Among Brand Names of Tablets and Capsules: A Cross-Sectional Survey in Thailand

    Teeraporn Sadira Supapaan, Jirawat Kamnuek, Chanawat Khakaew, Thanakorn Jungsuwadee, Ananya Songmuang, Saksit Sripa, Peerawat Jinatongthai, Chonladda Pitchayajittipong, Jintana Napaporn

    pp. 2955 · DOI: 10.18549/PharmPract.2024.3.2955 · Published Jul-Sep 2024

    Background: Look-Alike, Sound-Alike (LASA) drugs pose significant risks to patient safety due to potential medication errors, primarily from confusion over drug names. Such issues are of global concern and are pervasive …

12. Article

    Impact of a Depression-Specific Pharmaceutical Care Counseling and Smartphone App in Medication Adherence among Patients with Major Depressive Disorders: A pilot study

    Kotchakorn Nianmongkon, Tanaporn Samphao, Panpachara Nuchchom, Jannapas Tharavichitkun, Rewadee Jenraumjit

    pp. 2969 · DOI: 10.18549/PharmPract.2024.1.2969 · Published 1 August 2024

    Introduction: Medication nonadherence has a number of clinical consequences, including an increased risk of relapse and recurrence. By offering individualized in-person pharmaceutical care counseling, pharmacists play a …

13. Article

    Novel C7 anisidinoquinolones with advantageous antibacterial activity in nanoscale concentrations against standard and resistant bacterial strains

    Somia M. ElSheikhi, Rula M. Darwish, Yusuf Al-Hiari, Violet Kasabri, Mohammed A.F. Salih

    pp. 2970 · DOI: 10.18549/PharmPract.2024.3.2970 · Published 4 July 2024

    Background: The extensive clinical use of Fluoroquinolones (FQs) led to the development of bacterial resistance against these agents. In this work, new lipophilic FQs were designed, prepared and screened against standard…

14. Article

    Parental knowledge, attitudes and practices on the use of antibiotics in children: a cross-sectional study in UAE

    Doaa Kamal Alkhalidi, Semira A. Beshir, Amina Mahdy, Eiman Shamseldin Al Gailani, Maryam Hassan Alyasi, Moumena Muwaffak Tlelat, Fatoum Taha Alward, Hawraa Mohammed Ahmed

    pp. 2973 · DOI: 10.18549/PharmPract.2024.3.2973 · Published 18 July 2024

    Background: Lack of parental education and a poor attitude are major factors in the emergence of antibiotic resistance. Our goal was to compile information on parents' knowledge, attitudes, and practices (KAP) on the usa…

15. Article

    Nature and extent of direct cost of left over and expired medications: A community-based study

    Jisha M Lucca, Dhafer Mahdi Alshayban, Royes Joseph, Noorah Alghamdi, Hajar Abdullah, Shouq Altowairqi

    pp. 2974 · DOI: 10.18549/PharmPract.2024.3.2974 · Published Jul-Sep 2024

    Background: Medications including unused ones, might lead to financial and environmental costs. Not only they could have economic impact but also, harm the population safety. However, the nature and extent of leftover an…

16. Article

    A brief motivational interview for smoking cessation by Belgian community pharmacists

    Delphine Vauterin, Eline Tommelein, Lies Lahousse

    pp. 2976 · DOI: 10.18549/PharmPract.2024.3.2976 · Published 12 July 2024

    Background: Community pharmacy-delivered interventions for smoking cessation are effective. The impact of behavioural interventions on short-term health benefits remains unclear. Objective: We aimed to evaluate a communi…

17. Article

    An analysis of in-hospital enoxaparin prescription and bleeding in the predominately middle-, and oldest-old population: insights from a secondary care hospital

    Angsunid Porncatatak, Sathaporn Khananthai, Mathumalar Loganathan, Supatat Chumnumwat

    pp. 2979 · DOI: 10.18549/PharmPract.2024.3.2979 · Published 4 July 2024

    Background: Enoxaparin is one of the widely used injectable anticoagulants requiring dose adjustment based on body weight and renal function. Unadjusted or inappropriately adjusted doses can lead to thromboembolic or ble…

18. Article

    Impacts of pharmacists-managed outpatient clinic in patients with hepatitis c virus infection: A retrospective study in China

    Can Huang, Aiping Gao, Cuixia Guo, Jinmei Jia, Yonghong Zheng, Wei Liu

    pp. 2986 · DOI: 10.18549/PharmPract.2024.3.2986 · Published 5 July 2024

    Objective: Pharmacists are health care professionals who are actively involved in identifying and solving drug-related problems (DRPs) in patients with hepatitis C virus (HCV) infection. However, the effectiveness of pha…

19. Article

    Spironolactone suspension for paediatric use: formulation, quality and stability

    Francesca Baratta, Chiara Zingarelli, Fedor Felismè, Editson Lamy, Romel Cajuste, Pierre Hugues Saint-Jean, Emanuela Ambreck, Gaetano Di Lascio, Paola Brusa

    pp. 2987 · DOI: 10.18549/PharmPract.2024.3.2987 · Published 14 July 2024

    Background: The compounding of extemporaneous preparations has historically been an essential part of the pharmacist's role, and, even today, its importance is recognized in all regulatory frameworks worldwide. The paedi…

20. Article

    An overview of the experience of Iraqi COVID-19 patients, and the role of the pharmacists during their infection

    Razan I. Nassar, Iman A. Basheti, Alhareth Ahmad, Shaymaa Al-Majmaie, Dima Awajan, Ruaa R. Al-Alwany, Ayman Nassar, Samar Thiab

    pp. 2994 · DOI: 10.18549/PharmPract.2024.3.2994 · Published 19 July 2024

    Background: The global healthcare systems have faced significant challenges due to the COVID-19 pandemic. Pharmacists have been frontline healthcare workers playing a pivotal role during this pandemic. This study aimed t…

21. Article

    Clinical and cost avoidance benefits of integrating pharmacist in intensive care unit

    Nadia H. Ismail, Hadeel S. AL-Harbi

    pp. 2999 · DOI: 10.18549/PharmPract.2024.3.2999 · Published 2 August 2024

    Introduction: Critical care pharmacists as integral members of multidisciplinary teams, play a crucial role in enhancing clinical, economic, and humanistic outcomes for all critically ill patients. In this region, howeve…

22. Article

    Recommendation discrepancies between vaccine licensure and vaccination practices: knowledge, practice, and attitude of healthcare providers

    Jakub N. Khzouz, Shereen M. Aleidi, Rima A. Hijazeen, Abla M Albsoul-Younes, Mohammad H. Alajmi, Sief-Addeen B Shehadeh

    pp. 3002 · DOI: 10.18549/PharmPract.2024.3.3002 · Published Jul-Sep 2024

    Objectives: This study aimed to identify discrepancies between Jordan Food and Drug Administration (JFDA) vaccine licensure indications and directorate of communicable diseases (DCD) on immunization practices recommendat…

23. Article

    Analysis Implementation of Medication Timeline (ME TIME) on the workload of clinical pharmacy services in inpatient care: A randomized controlled trial

    Samirah, Hasbi As-Shiddiq, Mareta R Andarsari, Agriawan Sudirman, Lily Aina, Yulistiani, Satriyo D Suryantoro, Arina D Puspitasari, Dinda M N Ratri

    pp. 3011 · DOI: 10.18549/PharmPract.2024.3.3011 · Published 17 July 2024

    Background: The role of hospital clinical pharmacists is to minimize, if not eliminate, errors in drug administration. However, the number of clinical pharmacists employed in a hospital is often limited, which results in…

24. Article

    Assessment of experience, fears, barriers and adherence to insulin injection among the parents of early-diagnosed children with Diabetes

    Muna Barakat, Souheil Hallit, Diana Malaeb, Malik Sallam, Marah Al-Jamal, Sara Ibrahim, Huda M. Alshammari, Sara Feras Abuarab, Rasha Odeh, Abeer Alassaf

    pp. 3015 · DOI: 10.18549/PharmPract.2024.3.3015 · Published 23 July 2024

    Background: Regardless of the indisputable benefits of insulin therapy, initiating insulin for newly diagnosed type-1 children with diabetes might be intimidating for parents. This study assesses the experience, fears, b…